American Cancer Society prostate cancer survivorship care guidelines. (Q48073617)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

American Cancer Society prostate cancer survivorship care guidelines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

Jeanny B Aragon-Ching

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Michael J Zelefsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

Ted A Skolarus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Andrew M D Wolf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Nicole L Erb

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Durado D Brooks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Brian M Rivers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Willie Underwood

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Andrew L Salner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Susan F Slovin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Daniela A Wittmann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Michael A Hoyt

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Victoria J Sinibaldi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Gerald Chodak

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mandi L Pratt-Chapman

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Rebecca L Cowens-Alvarado

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

10 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

225-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24916760%20AND%20SRC:MED&resulttype=core&format=json

Survivorship: adult cancer survivors

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prostate cancer survivorship: lessons from caring for the uninsured

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Time trends and local variation in primary treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Disproportionate presentation of high risk prostate cancer in a safety net health system

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prostate cancer epidemiology in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Life-Threatening Disparities: The Treatment of Black and White Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Cancer survivorship research: a review of the literature and summary of current NCI-designated cancer center projects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Management of complications of prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Long-term functional outcomes after treatment for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

"The only way I know how to live is to work": a qualitative study of work following treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Determinants of treatment regret in low-income, uninsured men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Geographic and socioeconomic variation in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The quality-of-life impact of prostate cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The effect of ethnicity and sexual preference on prostate-cancer-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

New American Cancer Society process for creating trustworthy cancer screening guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Nutrition and physical activity guidelines for cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Perceptions of cancer-related information among cancer survivors: a report from the American Cancer Society's Studies of Cancer Survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

What should we tell prostate cancer patients about (secondary) prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The role of obesity in cancer survival and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Energetics in colorectal and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Primary care perspectives on prostate cancer survivorship: implications for improving quality of care

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Secondary malignancies following radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Increased risk of rectal cancer after prostate radiation: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Despite some comprehension problems the International Index of Erectile Function is a reliable questionnaire in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Management of side effects of androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Hematological changes during androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prospective assessment of outcomes in 411 patients treated with hyperbaric oxygen for chronic radiation tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Metabolic complications of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Androgen deprivation therapy: evidence-based management of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Psychosocial consequences of prostate cancer: 30 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The burden of depression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

A Literature Review of Suicide in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Incidence of suicide in persons with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

What contributes more strongly to predicting QOL during 1-year recovery from treatment for clinically localized prostate cancer: 4-weeks-post-treatment depressive symptoms or type of treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Race by sex differences in depression symptoms and psychosocial service use among non-Hispanic black and white patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

What precipitates depression in African-American cancer patients? Triggers and stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Screening for Distress in Lung and Breast Cancer Outpatients: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The validity of the distress thermometer in prostate cancer populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Effects of screening for psychological distress on patient outcomes in cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Quality of life issues in men undergoing androgen deprivation therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Management of complications of androgen deprivation therapy in the older man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Uncertainty and perception of danger among patients undergoing treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The role of anxiety in prostate carcinoma: a structured review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Emerging cardiometabolic complications of androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Bone health in men receiving androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Aging and osteoporosis in breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Bone health and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Osteoporosis in men: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prediction of erectile function following treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Current state of penile rehabilitation after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Penile rehabilitation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Erectile aid use by men treated for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Rehabilitation of erectile function following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Tadalafil rehabilitation therapy preserves penile size after bilateral nerve sparing radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Orgasm-associated urinary incontinence and sexual life after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The resurgence of the vacuum erection device (VED) for treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Vacuum therapy in erectile dysfunction--science and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

SOP conservative (medical and mechanical) treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Depression is correlated with the psychological and physical aspects of sexual dysfunction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Psychological aspects of prostate cancer: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The psychosocial aspects of sexual recovery after prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Body image predicts quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Sexual function with localized prostate cancer: active surveillance vs radical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Determinants of sexual satisfaction in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Couple distress after localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

From a woman's perspective: life as a partner of a prostate cancer survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Prostate cancer patients and their partners: differences in satisfaction indices and psychological variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Interdependent psychological quality of life in dyads adjusting to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Patient centered outcomes in prostate cancer treatment: predictors of satisfaction up to 2 years after open radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Couples surviving prostate cancer: challenges in their lives and relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Counseling patients about sexual health when considering post-prostatectomy radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Coping with sexual concerns after cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Coping with sexual concerns after cancer: the use of flexible coping

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Partners of cancer patients consult their GPs significantly more often with both somatic and psychosocial problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Spousal responses to prostate cancer: an integrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Problem-solving and distress in prostate cancer patients and their spousal caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Developmental life stage and couples' experiences with prostate cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Practical evaluation of post-prostatectomy incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Factors predicting early return of continence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Understanding early functional recovery after robotic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Diagnostic challenges in the evaluation of persistent or recurrent urinary incontinence after artificial urinary sphincter (AUS) implantation in patients after prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Male incontinence surgery in the 21st century: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Update on management of post-prostatectomy incontinence in 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Risk factors, pathophysiology, and treatment of hot flashes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Hot flashes in prostate cancer: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Luteinizing hormone--releasing hormone agonists: a quick reference for prevalence rates of potential adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Management of hot flashes in men with prostate cancer being treated with androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

For which health problems do cancer survivors visit their General Practitioner?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21234